Llwytho...

Docetaxel-Carboxymethylcellulose Nanoparticles Display Enhanced Anti-tumor Activity in Murine Models of Castration-Resistant Prostate Cancer

Docetaxel (DTX) remains the only effective drug for prolonging survival and improving quality of life of metastatic castration resistant prostate cancer (mCRPC) patients. Despite some clinical successes with DTX-based therapies, advent of cumulative toxicity and development of drug resistance limit...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Hoang, Bryan, Ernsting, Mark J., Murakami, Mami, Undzys, Elijus, Li, Shyh-Dar
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2014
Pynciau:
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4074574/
https://ncbi.nlm.nih.gov/pubmed/24853460
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijpharm.2014.05.021
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!